V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260006226 | 260004624 | 1.72 | 90 | Palliative (P) | 2015-11-16 | 2015-11-16 | BENDAMUSTINE + RITUXIMAB | null | N | 260023418 | BENDAMUSTINE + RITUXIMAB |
| 260006227 | 260004625 | 1.61 | 72.6 | Curative (C) | 2016-03-12 | 2016-03-16 | Bendamustine+Rituximab(Sub Courses) | 2 | N | 260023420 | BENDAMUSTINE + RITUXIMAB |
| 260006228 | 260011190 | 1.85 | 87 | Curative (C) | 2014-02-01 | 2014-02-22 | BENDAMUSTINE + RITUXIMAB | N | N | 260023422 | BENDAMUSTINE + RITUXIMAB |
| 260006229 | 260004626 | 1.71 | 74 | Palliative (P) | 2016-12-11 | 2016-12-26 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260023427 | BENDAMUSTINE + RITUXIMAB |
| 260006230 | 260004626 | 1.84 | 72 | Not known (9) | 2014-05-28 | 2014-06-02 | Bendamustine+Rituximab (1st Course) | N | N | 260023427 | BENDAMUSTINE + RITUXIMAB |
| 260006231 | 260004627 | 1.78 | 76.4 | Disease modification (D) | 2018-03-20 | 2018-03-20 | BENDAMUSTINE + RITUXIMAB | N | N | 260023429 | BENDAMUSTINE + RITUXIMAB |
| 260006232 | 260004627 | 1.6 | 67.7 | null | 2014-09-25 | 2014-10-01 | BENDAMUSTINE + RITUXIMAB | N | N | 260023429 | BENDAMUSTINE + RITUXIMAB |
| 260006233 | 260004628 | null | null | Disease modification (D) | 2011-08-25 | 2016-08-04 | BENDAMUSTINE + RITUXIMAB | null | N | 260023435 | BENDAMUSTINE + RITUXIMAB |
| 260006234 | 260004629 | 1.7 | null | Disease modification (D) | 2018-02-02 | 2018-02-04 | BENDAMUSTINE + RITUXIMAB | 2 | N | 260023436 | BENDAMUSTINE + RITUXIMAB |
| 260006235 | 260004629 | null | null | null | 2014-06-29 | 2014-08-03 | BENDAMUSTINE + RITUXIMAB | N | N | 260023436 | BENDAMUSTINE + RITUXIMAB |
| 260006236 | 260004629 | 1.65 | 93 | Disease modification (D) | 2014-04-26 | 2014-04-29 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260023436 | BENDAMUSTINE + RITUXIMAB |
| 260006237 | 260004630 | 1.81 | 50.7 | Palliative (P) | 2017-10-17 | 2017-10-17 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260023441 | BENDAMUSTINE + RITUXIMAB |
| 260006238 | 260004630 | 1.76 | 90 | Disease modification (D) | 2016-05-21 | 2016-06-05 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260023441 | BENDAMUSTINE + RITUXIMAB |
| 260006239 | 260004630 | 1.79 | 93.8 | Curative (C) | null | 2017-12-04 | BENDAMUSTINE + RITUXIMAB | N | N | 260023441 | BENDAMUSTINE + RITUXIMAB |
| 260006240 | 260017285 | 1.67 | 153.8 | Disease modification (D) | 2016-08-03 | 2016-08-05 | BENDAMUSTINE + RITUXIMAB | 2 | N | 260023453 | BENDAMUSTINE + RITUXIMAB |
| 260006241 | 260017285 | 1.6 | 97 | Curative (C) | 2014-07-30 | 2014-08-08 | BENDAMUSTINE + RITUXIMAB | N | null | 260023453 | BENDAMUSTINE + RITUXIMAB |
| 260006242 | 260004631 | 1.6 | 77 | Disease modification (D) | 2017-06-18 | 2017-06-27 | Bendamustine+Rituximab (1st Course) | N | Y | 260023458 | BENDAMUSTINE + RITUXIMAB |
| 260006243 | 260004631 | 1.71 | 70.4 | Disease modification (D) | 2016-12-02 | 2016-12-09 | Bendamustine+Rituximab(Sub Courses) | 02 | N | 260023458 | BENDAMUSTINE + RITUXIMAB |
| 260006244 | 260004632 | 1.81 | 67.5 | Disease modification (D) | 2017-11-27 | 2017-11-28 | Bendamustine+Rituximab(Sub Courses) | N | N | 260023468 | BENDAMUSTINE + RITUXIMAB |
| 260006245 | 260004632 | 1.59 | 76 | Disease modification (D) | 2013-10-28 | 2013-10-29 | Bendamustine+Rituximab (1st Course) | 02 | N | 260023468 | BENDAMUSTINE + RITUXIMAB |
| 260006246 | 260004633 | 1.95 | null | Not known (9) | 2015-12-24 | 2015-12-26 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260023470 | BENDAMUSTINE + RITUXIMAB |
| 260006247 | 260004634 | null | null | Disease modification (D) | 2016-10-11 | 2016-11-04 | Bendamustine+Rituximab(Sub Courses) | N | N | 260023472 | BENDAMUSTINE + RITUXIMAB |
| 260006248 | 260004635 | 1.79 | 74.4 | Disease modification (D) | null | 2015-04-26 | Bendamustine+Rituximab (1st Course) | N | N | 260023473 | BENDAMUSTINE + RITUXIMAB |
| 260006249 | 260004636 | 1.65 | 55 | null | 2014-06-30 | 2014-06-30 | BENDAMUSTINE + RITUXIMAB | 99 | N | 260023474 | BENDAMUSTINE + RITUXIMAB |
| 260006250 | 260011197 | 1.92 | 67.3 | Not known (9) | 2017-10-11 | 2017-10-12 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260023476 | BENDAMUSTINE + RITUXIMAB |
| 260006251 | 260011197 | 1.7 | 102 | Palliative (P) | 2013-09-02 | 2013-09-14 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260023476 | BENDAMUSTINE + RITUXIMAB |
| 260006252 | 260004637 | 1.64 | null | Palliative (P) | null | 2017-11-26 | BENDAMUSTINE + RITUXIMAB | N | N | 260023478 | BENDAMUSTINE + RITUXIMAB |
| 260006253 | 260004637 | 1.45 | 53 | Palliative (P) | 2016-10-24 | 2016-10-25 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260023478 | BENDAMUSTINE + RITUXIMAB |
| 260006254 | 260004638 | null | 92 | Curative (C) | 2017-03-10 | 2017-03-21 | BENDAMUSTINE + RITUXIMAB | N | N | 260023483 | BENDAMUSTINE + RITUXIMAB |
| 260006255 | 260004638 | 1.68 | 63.5 | Palliative (P) | 2015-09-23 | 2015-09-28 | Bendamustine+Rituximab (1st Course) | 02 | N | 260023483 | BENDAMUSTINE + RITUXIMAB |
| 260006256 | 260004639 | 1.77 | 110 | Palliative (P) | 2014-03-25 | 2014-03-27 | Bendamustine+Rituximab (1st Course) | 02 | N | 260023487 | BENDAMUSTINE + RITUXIMAB |
| 260006257 | 260004639 | 1.68 | 118.4 | Palliative (P) | 2017-05-12 | 2017-05-13 | BENDAMUSTINE + RITUXIMAB | N | N | 260023487 | BENDAMUSTINE + RITUXIMAB |
| 260006258 | 260004640 | 1.66 | 81 | Palliative (P) | 2015-10-06 | 2015-10-27 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260023489 | BENDAMUSTINE + RITUXIMAB |
| 260006259 | 260004641 | 1.58 | 74 | Disease modification (D) | 2015-01-15 | 2015-01-17 | BENDAMUSTINE + RITUXIMAB | N | N | 260023490 | BENDAMUSTINE + RITUXIMAB |
| 260006260 | 260004641 | 1.74 | 80.5 | Palliative (P) | 2017-07-26 | 2017-07-26 | Bendamustine+Rituximab(Sub Courses) | N | N | 260023490 | BENDAMUSTINE + RITUXIMAB |
| 260006261 | 260004642 | null | null | Palliative (P) | 2014-02-27 | 2014-02-27 | BENDAMUSTINE + RITUXIMAB | N | null | 260023495 | BENDAMUSTINE + RITUXIMAB |
| 260006262 | 260004643 | 1.68 | 70.2 | Curative (C) | 2014-06-14 | 2014-06-21 | BENDAMUSTINE + RITUXIMAB | 2 | N | 260023496 | BENDAMUSTINE + RITUXIMAB |
| 260006263 | 260004644 | 1.59 | 63 | Disease modification (D) | 2018-01-01 | 2018-01-05 | BENDAMUSTINE + RITUXIMAB | N | N | 260023497 | BENDAMUSTINE + RITUXIMAB |
| 260006264 | 260004644 | null | null | null | null | 2017-06-05 | BENDAMUSTINE + RITUXIMAB | null | N | 260023497 | BENDAMUSTINE + RITUXIMAB |
| 260006265 | 260004644 | 1.92 | 73.3 | Disease modification (D) | 2017-09-25 | 2017-09-29 | Bendamustine+Rituximab (1st Course) | 02 | N | 260023497 | BENDAMUSTINE + RITUXIMAB |
| 260006266 | 260004644 | 1.45 | 58.1 | Palliative (P) | 2015-09-23 | 2015-09-26 | Bendamustine+Rituximab (1st Course) | 02 | N | 260023497 | BENDAMUSTINE + RITUXIMAB |
| 260006267 | 260004644 | null | 56 | Curative (C) | null | 2014-01-26 | BENDAMUSTINE + RITUXIMAB | N | null | 260023497 | BENDAMUSTINE + RITUXIMAB |
| 260006268 | 260004645 | 1.58 | 82 | Not known (9) | 2015-10-08 | 2015-10-15 | BENDAMUSTINE + RITUXIMAB | N | N | 260023510 | BENDAMUSTINE + RITUXIMAB |
| 260006269 | 260004645 | 1.67 | 98 | Disease modification (D) | null | 2014-10-22 | BENDAMUSTINE + RITUXIMAB | N | N | 260023510 | BENDAMUSTINE + RITUXIMAB |
| 260006270 | 260004645 | null | 91 | Palliative (P) | 2016-10-24 | 2016-11-20 | BENDAMUSTINE + RITUXIMAB | N | null | 260023510 | BENDAMUSTINE + RITUXIMAB |
| 260006271 | 260004645 | 1.57 | 83 | Disease modification (D) | 2017-09-28 | 2017-09-28 | BENDAMUSTINE + RITUXIMAB | N | N | 260023510 | BENDAMUSTINE + RITUXIMAB |
| 260006272 | 260004646 | 1.6 | 74 | Unknown (U) | 2015-09-17 | 2015-10-31 | BENDAMUSTINE + RITUXIMAB | N | Y | 260023518 | BENDAMUSTINE + RITUXIMAB |
| 260006273 | 260004646 | 1.84 | 87 | Disease modification (D) | 2013-02-12 | 2013-02-12 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260023518 | BENDAMUSTINE + RITUXIMAB |
| 260006274 | 260015251 | 1.73 | 66 | Disease modification (D) | 2015-04-04 | 2015-04-12 | Bendamustine+Rituximab (1st Course) | N | N | 260023523 | BENDAMUSTINE + RITUXIMAB |
| 260006275 | 260015251 | 1.72 | 82.9 | Palliative (P) | 2014-06-20 | 2014-07-12 | BENDAMUSTINE + RITUXIMAB | N | N | 260023523 | BENDAMUSTINE + RITUXIMAB |